chr6-152430143-G-T

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBA1

The NM_182961.4(SYNE1):​c.4757C>A​(p.Thr1586Lys) variant causes a missense change. The variant allele was found at a frequency of 0.00443 in 1,602,944 control chromosomes in the GnomAD database, including 168 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0063 ( 20 hom., cov: 33)
Exomes 𝑓: 0.0042 ( 148 hom. )

Consequence

SYNE1
NM_182961.4 missense

Scores

6
12

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 4.38
Variant links:
Genes affected
SYNE1 (HGNC:17089): (spectrin repeat containing nuclear envelope protein 1) This gene encodes a spectrin repeat containing protein expressed in skeletal and smooth muscle, and peripheral blood lymphocytes, that localizes to the nuclear membrane. Mutations in this gene have been associated with autosomal recessive spinocerebellar ataxia 8, also referred to as autosomal recessive cerebellar ataxia type 1 or recessive ataxia of Beauce. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), SYNE1. . Gene score misZ -0.29069 (greater than the threshold 3.09). Trascript score misZ 3.2909 (greater than threshold 3.09). GenCC has associacion of gene with autosomal recessive ataxia, Beauce type, autosomal recessive myogenic arthrogryposis multiplex congenita, Emery-Dreifuss muscular dystrophy 4, autosomal dominant, arthrogryposis multiplex congenita 3, myogenic type, autosomal dominant Emery-Dreifuss muscular dystrophy.
BP4
Computational evidence support a benign effect (MetaRNN=0.0025706887).
BP6
Variant 6-152430143-G-T is Benign according to our data. Variant chr6-152430143-G-T is described in ClinVar as [Likely_benign]. Clinvar id is 130445.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.062 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SYNE1NM_182961.4 linkuse as main transcriptc.4757C>A p.Thr1586Lys missense_variant 36/146 ENST00000367255.10 NP_892006.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SYNE1ENST00000367255.10 linkuse as main transcriptc.4757C>A p.Thr1586Lys missense_variant 36/1461 NM_182961.4 ENSP00000356224 P1Q8NF91-1
SYNE1ENST00000423061.6 linkuse as main transcriptc.4778C>A p.Thr1593Lys missense_variant 36/1461 ENSP00000396024
SYNE1ENST00000461872.6 linkuse as main transcriptn.4975C>A non_coding_transcript_exon_variant 34/551
SYNE1ENST00000367253.8 linkuse as main transcriptc.4757C>A p.Thr1586Lys missense_variant 34/365 ENSP00000356222 Q8NF91-6

Frequencies

GnomAD3 genomes
AF:
0.00626
AC:
952
AN:
152036
Hom.:
19
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00123
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0316
Gnomad ASJ
AF:
0.00519
Gnomad EAS
AF:
0.0368
Gnomad SAS
AF:
0.00310
Gnomad FIN
AF:
0.0111
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000956
Gnomad OTH
AF:
0.00622
GnomAD3 exomes
AF:
0.0108
AC:
2573
AN:
238176
Hom.:
49
AF XY:
0.00897
AC XY:
1153
AN XY:
128510
show subpopulations
Gnomad AFR exome
AF:
0.000985
Gnomad AMR exome
AF:
0.0418
Gnomad ASJ exome
AF:
0.00526
Gnomad EAS exome
AF:
0.0351
Gnomad SAS exome
AF:
0.00294
Gnomad FIN exome
AF:
0.0110
Gnomad NFE exome
AF:
0.000904
Gnomad OTH exome
AF:
0.00767
GnomAD4 exome
AF:
0.00424
AC:
6152
AN:
1450792
Hom.:
148
Cov.:
30
AF XY:
0.00406
AC XY:
2931
AN XY:
721104
show subpopulations
Gnomad4 AFR exome
AF:
0.000751
Gnomad4 AMR exome
AF:
0.0415
Gnomad4 ASJ exome
AF:
0.00457
Gnomad4 EAS exome
AF:
0.0640
Gnomad4 SAS exome
AF:
0.00366
Gnomad4 FIN exome
AF:
0.0113
Gnomad4 NFE exome
AF:
0.000426
Gnomad4 OTH exome
AF:
0.00440
GnomAD4 genome
AF:
0.00627
AC:
954
AN:
152152
Hom.:
20
Cov.:
33
AF XY:
0.00759
AC XY:
565
AN XY:
74396
show subpopulations
Gnomad4 AFR
AF:
0.00123
Gnomad4 AMR
AF:
0.0317
Gnomad4 ASJ
AF:
0.00519
Gnomad4 EAS
AF:
0.0371
Gnomad4 SAS
AF:
0.00311
Gnomad4 FIN
AF:
0.0111
Gnomad4 NFE
AF:
0.000956
Gnomad4 OTH
AF:
0.00568
Alfa
AF:
0.00235
Hom.:
6
Bravo
AF:
0.00809
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.000682
AC:
3
ESP6500EA
AF:
0.00140
AC:
12
ExAC
AF:
0.00844
AC:
1023
Asia WGS
AF:
0.0220
AC:
77
AN:
3462

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Feb 14, 2015- -
Likely benign, no assertion criteria providedclinical testingGenetic Services Laboratory, University of Chicago-Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -
Benign, criteria provided, single submitterclinical testingGeneDxMay 24, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
not provided Benign:2
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsJun 12, 2019- -
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJul 01, 2024SYNE1: BP4, BS1, BS2 -
Autosomal recessive ataxia, Beauce type;C2751807:Emery-Dreifuss muscular dystrophy 4, autosomal dominant Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Autosomal recessive ataxia, Beauce type Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Autosomal recessive ataxia, Beauce type;C2751807:Emery-Dreifuss muscular dystrophy 4, autosomal dominant;C5193121:Arthrogryposis multiplex congenita 3, myogenic type Benign:1
Likely benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsApr 25, 2022- -
Emery-Dreifuss muscular dystrophy 4, autosomal dominant Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.34
CADD
Benign
22
DANN
Benign
0.95
DEOGEN2
Benign
0.20
T;.;T;.
Eigen
Benign
0.047
Eigen_PC
Uncertain
0.25
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.91
D;T;D;D
MetaRNN
Benign
0.0026
T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.4
M;.;.;M
MutationTaster
Benign
0.97
D;D;D;D;D;N
PrimateAI
Benign
0.32
T
PROVEAN
Benign
-1.4
N;.;N;N
REVEL
Benign
0.13
Sift
Uncertain
0.017
D;.;D;T
Sift4G
Uncertain
0.0060
D;D;D;D
Polyphen
0.049
B;.;.;B
Vest4
0.25
MPC
0.19
ClinPred
0.021
T
GERP RS
6.0
Varity_R
0.27
gMVP
0.14

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs77675624; hg19: chr6-152751278; COSMIC: COSV55142609; COSMIC: COSV55142609; API